John Pinching from PharmaTimes - Journalist Profile

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cambridge scientists develop ‘super test’ for prostate cancer - 5 days ago Bath researchers awarded Wellcome grant for psychotic disorder study - 5 days ago Andembry treatment approved across Europe - 9 days ago Illuccix therapy gets approval in the UK - 9 days ago Amlenetug receives FDA Fast Track Designation - 11 days ago Bimekizumab shows long-term efficacy in hidradenitis suppurativa - 11 days ago Libtayo available in Scotland for cervical cancer patients - 11 days ago Lynparza approved in Scotland for BRCA-mutated breast cancer patients - 11 days ago Capgemini unveils AI breakthrough to boost bioeconomy - 12 days ago Hemgenix shows efficacy among haemophilia B patients - 12 days ago Qureight and Avalyn launch strategic partnership in pulmonary fibrosis - 17 days ago FDA grants Orphan Drug Designation to Ariceum cancer therapy - 17 days ago Rippon Ubhi - 17 days ago Novartis secures MHRA authorisation for ribociclib - 17 days ago Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies - 18 days ago Aplagon secures EUR 7 million for APAC phase 2a trials - 19 days ago CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients - 19 days ago Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials - about 1 month ago Actinogen boosts trial with Cambridge Cognition’s digital suite - about 1 month ago Owlstone Medical announces $27 million USD first close in Series E financing round - about 1 month ago Oxford Drug Design achieves in vivo validation for novel cancer treatment - about 1 month ago Pheno Therapeutics granted trial authorisation for MS candidate - about 1 month ago Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease - about 1 month ago AI set to revolutionise pharmaceutical R&D says GlobalData - about 1 month ago Gilead and LEO Pharma partner to develop oral STAT6 program - about 1 month ago Cambridge Cognition highlights positive Cantab results - about 2 months ago Angelini Ventures co-leads Series A financing in Neumirna Therapeutics - about 2 months ago Novartis gene therapy set to enhance SMA treatment - about 2 months ago Merck unveils new cyber-physical trust platform at CES 2025 - about 2 months ago New prostate cancer test cuts biopsies by 50% in US - about 2 months ago Amgen’s lung cancer treatment gets conditional approval - about 2 months ago NHS Confederation welcomes social care commission announcement - about 2 months ago FDA approves Sequana Medical’s Alfapump for ascites treatment - about 2 months ago EC approves Rybrevant with Lazcluze for advanced lung cancer - about 2 months ago UK regulator warns against buying weight-loss medicines without prescription - about 2 months ago MindMed begins phase 3 study of MM120 for anxiety disorder - 2 months ago German cancer centre treats first patient with Elekta Evo - 2 months ago CSL receives positive opinion for garadacimab in hereditary angioedema - 2 months ago Beckley Psytech announces positive results for ELE-101 in depression trial - 2 months ago Bayer begins inhibitor study treating advanced KRAS-mutated tumours - 2 months ago Leriglitazone meets primary endpoint in pivotal cALD trial - 2 months ago iOnctura achieves new clinical milestones in uveal melanoma therapy - 2 months ago Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy - 2 months ago Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 2 months ago CatalYm shows potential of visugromab for treating cachexia - 2 months ago Imfinzi receives NICE recommendation for lung cancer treatment - 3 months ago Poolbeg Pharma presents positive results for POLB 001 - 3 months ago Teva’s Ajovy shows positive results in preventing pediatric migraines - 3 months ago NICE endorses Neuraxpharm’s ublituximab for treating MS - 3 months ago Antag Therapeutics secures €80 million in weight loss therapy financing - 3 months ago
2	Urte Jakimaviciute PharmaTimes	AI set to revolutionise pharmaceutical R&D says GlobalData - about 1 month ago
3	Christie Wong PharmaTimes	Novartis gene therapy set to enhance SMA treatment - about 2 months ago